Shanghai Yizhong Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 166.32 million. Net income was CNY 104.17 million compared to net loss of CNY 20.12 million a year ago.

Basic earnings per share from continuing operations was CNY 0.6551 compared to basic loss per share from continuing operations of CNY 0.1604 a year ago. Diluted earnings per share from continuing operations was CNY 0.6551 compared to diluted loss per share from continuing operations of CNY 0.1604 a year ago.